SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India reports 63% rise in Q1 net profit

26 Apr 2022 Evaluate

Sanofi India has reported results for first quarter ended March 31, 2022.

The company has reported 63.40% rise in its net profit at Rs 238.40 crore for the quarter under review as compared to net profit of Rs 145.90 crore for the same quarter in the previous year. However, total income of the company decreased by 2.66% at Rs 731.40 crore for March quarter as compared Rs 751.40 crore for the corresponding quarter previous year.

Sanofi India is a global biopharmaceutical company focused on human health.

Sanofi India Share Price

3578.55 18.75 (0.53%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×